
Twelve years of multiples investors have paid for Uniphos Enterprises Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Uniphos Enterprises Ltd trades at a P/E of 42.12×.
Twelve years of audited numbers for Uniphos Enterprises Ltd, switchable between annual and quarterly views, consolidated or standalone.
Uniphos Enterprises Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹799.777 Cr and reported EPS of ₹2.73.
Disclosed business segments at Uniphos Enterprises with their share of revenue and profit, switchable between consolidated and standalone reporting.
Uniphos Enterprises discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Why someone would buy Uniphos Enterprises Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Uniphos Enterprises Ltd's investment case rests on 9 positive markers and 9 flagged concerns drawn from the latest reported filings.
Promoter holding is robust at 73.8%, indicating strong management confidence.
Zero debt-to-equity ratio (0.00) provides significant financial stability.
Stock trades below book value (0.39 P/B), potentially indicating an undervalued asset.
Substantial quarterly sales growth of 93.40% signals positive revenue momentum.
Increasing FII holding (15.71%) suggests growing external investor interest.
Reported negative quarterly profit after tax of -0.74 Cr.
Extremely low ROCE (0.06%) and ROE (0.01%) indicate poor capital returns.
Quarterly profit after tax declined drastically by -393.00%.
Negative EPS (-0.0382) reflects unprofitable operations, unattractive for investors.
Negative operating profit margin (-4.05%) highlights significant operational inefficiencies.
Trim if P/E re-rates above 55. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Uniphos Enterprises Ltd is highlighted for quick read-across.
| Company Name |
|---|
Uniphos Enterprises LtdCurrent Stock |
Vinyl Chemicals (I) Ltd |
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Uniphos Enterprises Ltd — derived from the live tape, not yesterday's close.
Uniphos Enterprises Ltd last traded at ₹105.24 with an intraday range of ₹104–₹106.57 — live indicator, pivot and CPR signals below.
Standard pivot — most widely referenced.
| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 111.68 | +6.44 | +6.12% |
| R3 | 109.11 | +3.87 | +3.68% |
| R2 | 107.84 | +2.60 | +2.47% |
| R1 | 106.54 | +1.30 | +1.24% |
| PIVOT | 105.27 | 0.03 | 0.03% |
| CURRENT | 105.24 | — | — |
| S1 | 98.83 | -6.41 | -6.09% |
| S2 | 101.40 | -3.84 | -3.65% |
| S3 | 102.70 | -2.54 | -2.41% |
| S4 | 103.97 | -1.27 | -1.21% |
UNIENTER is trading Below CPR, indicating Bearishness
CPR is Narrower, suggesting likely for trending moves
Day's range: 105.25 ~ 106.9
Trading Below opening range, showing Bearishness
Daily traded volume and delivery percentage for Uniphos Enterprises Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Uniphos Enterprises Ltd stood at 61.0% of traded volume, against a 20-day average of 65.7%.
Filings Uniphos Enterprises sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Every dividend, stock split and bonus issue Uniphos Enterprises has declared, sequenced by announce and record date.
Uniphos Enterprises corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
What Uniphos Enterprises Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Uniphos Enterprises Ltd operates in the Trading Companies & Distributors industry under the Industrials sector, listed as NSE: UNIENTER, BSE: 500429.

Uniphos Enterprises Limited (UEL) is an Indian company primarily involved in the trading of chemicals and other products within the domestic market. This forms a core component of its business operations, encompassing the sourcing, distribution, and sale of a diverse range of chemical commodities. The specifics of these chemical products and their applications are not detailed in the provided information, but it's clear that chemical trading represents a significant aspect of UEL's revenue generation.
Beyond its chemical trading activities, UEL also participates in the investment sector. The company engages in investments in both listed (quoted) and unlisted (unquoted) securities. This diversification suggests a strategy aimed at balancing risk and potentially generating additional returns beyond the trading arm of the business. The nature and scale of these investments – whether in stocks, bonds, or other securities – remain unspecified in the provided context.
Established in 1969 and headquartered in Mumbai, India, UEL boasts a relatively long history in the Indian business landscape. This suggests a degree of established market presence and potentially strong relationships within the chemical and investment communities. The company's longevity might also indicate a resilient business model capable of adapting to evolving market conditions over several decades.
It's important to note that UEL operates as a subsidiary of Nerka Chemicals Private Limited. This organizational structure indicates that UEL's strategic direction and operational decisions are ultimately influenced by its parent company. The nature of the relationship between Nerka Chemicals and UEL, and the extent to which Nerka Chemicals provides resources or direction, are not detailed in the available information.
In summary, Uniphos Enterprises Limited functions as a multifaceted company operating within the chemical trading and investment sectors in India. Its long operational history and subsidiary status within a larger chemical entity provide context for understanding its position and activities within the Indian market. However, the specifics of its product range, investment portfolio, and the exact nature of its relationship with its parent company are not fully elaborated upon in the source material.
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
The current share price of Uniphos Enterprises Ltd (UNIENTER) is ₹105.24. Today, the stock has declined by ₹0.01 (0.01%), trading in a range of ₹104 to ₹106.57. The stock opened at ₹105.26 with a trading volume of 2,568 shares.
Uniphos Enterprises Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹799.78 crores, P/E ratio of 42.12, ROE of 0.77%, and ROCE of 0.06%. The dividend yield stands at 0.43%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Uniphos Enterprises Ltd (UNIENTER) is ₹168.5, while the 52-week low is ₹87.51. Currently trading at ₹105.24, the stock is 21.9% away from its 52-week low and 37.5% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Uniphos Enterprises Ltd stock at ₹105.24 depends on multiple factors. The stock is currently trading with a P/E ratio of 42.12 and P/B ratio of N/A. Today's performance shows a loss of 0.01%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Uniphos Enterprises Ltd offers a dividend yield of 0.43%, which means for every ₹100 invested at the current price of ₹105.24, you can expect to receive approximately ₹0.43 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Uniphos Enterprises Ltd's key financial metrics include: P/E Ratio: 42.12, P/B Ratio: N/A, ROE: 0.77%, ROCE: 0.06%, Dividend Yield: 0.43%, EPS: ₹2.73, Book Value: ₹394.22, Debt-to-Equity: 0.00, and Current Ratio: N/A. The company's market cap stands at ₹799.78 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Uniphos Enterprises Ltd stock opened at ₹105.26 and is currently trading at ₹105.24, showing a decline of ₹0.01 (0.01%). The intraday high is ₹106.57 and low is ₹104. The trading volume stands at 2,568 shares, indicating moderate market participation today.
Uniphos Enterprises Ltd has a Price-to-Earnings (P/E) ratio of 42.12, which means investors are willing to pay ₹42.12 for every ₹1 of earnings. With an EPS of ₹2.73, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Uniphos Enterprises Ltd (UNIENTER) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Peers, sector trends, screeners and strategy playbooks contextual to this stock.